A group of Norwegian firms successfully tested a controlled pancreatic disease infection on various salmon breeding families to test for robustness against infection.
Norwegian breeding company SalmoBreed, in collaboration with firms Pharmaq and Veso, managed to infect salmon with PD under controlled conditions, with a high mortality rate as the outcome.
“The results are highly positive, and so far it is more than obvious that different families have different levels of resistance to PD. The results will give us, and our customers, a far better basis on which to choose the 'right' families to breed from,” said Rune Stigum Olsen, head of research and development at SalmoBreed.
He
